Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 871

1.

Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.

Powell RJ, Jaff MR, Schroë H, Benko A, Diaz-Cartelle J, Müller-Hülsbeck S.

Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26976. [Epub ahead of print]

PMID:
28296239
2.

Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.

Darling JD, McCallum JC, Soden PA, Korepta L, Guzman RJ, Wyers MC, Hamdan AD, Schermerhorn ML.

J Vasc Surg. 2017 Mar 5. pii: S0741-5214(17)30192-1. doi: 10.1016/j.jvs.2017.01.024. [Epub ahead of print]

PMID:
28274753
3.

The effect of gender on outcomes after lower extremity revascularization.

Wang J, He Y, Shu C, Zhao J, Dubois L.

J Vasc Surg. 2017 Mar;65(3):889-906.e4. doi: 10.1016/j.jvs.2016.11.030. Review.

PMID:
28236929
4.

Angiosome Targeted PTA is More Important in Endovascular Revascularisation than in Surgical Revascularisation: Analysis of 545 Patients with Ischaemic Tissue Lesions.

Špillerová K, Settembre N, Biancari F, Albäck A, Venermo M.

Eur J Vasc Endovasc Surg. 2017 Feb 16. pii: S1078-5884(17)30055-2. doi: 10.1016/j.ejvs.2017.01.008. [Epub ahead of print]

PMID:
28215512
5.

Better survival for African and Hispanic/Latino Americans after infrainguinal revascularization in the Society for Vascular Surgery Vascular Quality Initiative.

Brothers TE, Zhang J, Mauldin PD, Tonnessen BH, Robison JG, Vallabhaneni R, Hallett JW Jr, Sidawy AN.

J Vasc Surg. 2017 Feb 8. pii: S0741-5214(16)31667-6. doi: 10.1016/j.jvs.2016.10.105. [Epub ahead of print]

PMID:
28189358
6.

Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.

Thott O, Granath F, Malmstedt J, Wahlgren CM.

Eur J Vasc Endovasc Surg. 2017 Mar;53(3):403-410. doi: 10.1016/j.ejvs.2016.12.014.

PMID:
28131536
7.

Long-Term Outcomes After Percutaneous Lower Extremity Arterial Interventions With Atherectomy vs. Balloon Angioplasty - Propensity Score-Matched Registry.

Janas A, Buszman PP, Milewski KP, Wiernek S, Janas K, Pruski M, Wojakowski W, Błachut A, Picheta W, Buszman P, Kiesz S.

Circ J. 2017 Feb 24;81(3):376-382. doi: 10.1253/circj.CJ-16-0856.

8.

Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.

Darling JD, McCallum JC, Soden PA, Guzman RJ, Wyers MC, Hamdan AD, Verhagen HJ, Schermerhorn ML.

J Vasc Surg. 2017 Mar;65(3):695-704. doi: 10.1016/j.jvs.2016.09.055.

PMID:
28073665
9.

Endovascular Versus Open Revascularization for Peripheral Arterial Disease.

Wiseman JT, Fernandes-Taylor S, Saha S, Havlena J, Rathouz PJ, Smith MA, Kent KC.

Ann Surg. 2017 Feb;265(2):424-430. doi: 10.1097/SLA.0000000000001676.

PMID:
28059972
10.

[Efficacy and safety of drug-coated balloon angioplasty in treatment of lower extremity arterial occlusive disease: a meta-analysis of 11 trials].

Ran K, Wang C, Zhao Y, Xiang Z.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Nov 20;36(11):1566-1572. Chinese.

PMID:
27881352
11.

Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.

Hicks CW, Najafian A, Farber A, Menard MT, Malas MB, Black JH 3rd, Abularrage CJ.

J Vasc Surg. 2016 Dec;64(6):1667-1674.e1. doi: 10.1016/j.jvs.2016.07.107.

PMID:
27871493
12.

Critical limb ischaemia and the response to bone marrow-derived cell therapy according to tcPO<sub>2</sub> measurement.

Maufus M, Antoinette Sevestre-Pietri M, Sessa C, Pignon B, Egelhofer H, Dupas S, Nguyen P, Genty C, Pernod G.

Vasa. 2017 Jan;46(1):23-28. doi: 10.1024/0301-1526/a000590.

PMID:
27869551
13.

Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events.

McDermott MM, Kramer CM, Tian L, Carr J, Guralnik JM, Polonsky T, Carroll T, Kibbe M, Criqui MH, Ferrucci L, Zhao L, Hippe DS, Wilkins J, Xu D, Liao Y, McCarthy W, Yuan C.

JACC Cardiovasc Imaging. 2016 Nov 3. pii: S1936-878X(16)30739-2. doi: 10.1016/j.jcmg.2016.08.012. [Epub ahead of print]

PMID:
27838307
14.

Direct Stenting in Patients with Acute Lower Limb Arterial Occlusions: Immediate and Long-Term Results.

Galanakis N, Kontopodis N, Peteinarakis I, Kehagias E, Ioannou CV, Tsetis D.

Cardiovasc Intervent Radiol. 2017 Feb;40(2):192-201. doi: 10.1007/s00270-016-1500-5.

PMID:
27826790
15.

The Prognostic Significance of Different Definitions for Angiosome-Targeted Lower Limb Revascularization.

Špillerová K, Biancari F, Settembre N, Albäck A, Venermo M.

Ann Vasc Surg. 2016 Sep 29. pii: S0890-5096(16)30855-X. doi: 10.1016/j.avsg.2016.06.040. [Epub ahead of print]

PMID:
27693605
16.

Arterial duplex for diagnosis of peripheral arterial emboli.

Crawford JD, Perrone KH, Jung E, Mitchell EL, Landry GJ, Moneta GL.

J Vasc Surg. 2016 Nov;64(5):1351-1356. doi: 10.1016/j.jvs.2016.04.005.

PMID:
27374063
17.

Lower Extremity Revascularization in End-Stage Renal Disease.

Jones DW, Dansey K, Hamdan AD.

Vasc Endovascular Surg. 2016 Nov;50(8):582-585. doi: 10.1177/1538574416674843.

PMID:
27770080
19.

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.

Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P, Harrap S, Poulter N, Matthews DR, Marre M, Chalmers J; ADVANCE Collaborative Group..

Cardiovasc Diabetol. 2016 Sep 2;15(1):129. doi: 10.1186/s12933-016-0446-x.

20.

Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes.

Varcoe RL, Schouten O, Thomas SD, Lennox AF.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1721-8. doi: 10.1016/j.jcin.2016.06.005.

PMID:
27539693

Supplemental Content

Loading ...
Support Center